澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEUREN PHARMACEUTICALS LTD

20.720

+0.2000.97%

成交量：35.20萬

成交額：729.16萬

市值：26.24億

市盈率：132.89

高：21.010

開：20.500

低：20.440

收：20.520

52周最高：23.588

52周最低：10.920

股本：1.27億

流通股本：1.08億

量比：0.95

換手率：0.32%

股息：- -

股息率：- -

每股收益(TTM):0.156

每股收益(LYR):0.233

淨資產收益率：6.17%

總資產收益率：2.58%

市淨率：7.87

市盈率(LYR):89.04

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+1.18%

資金流向

資金流入：

資金流出：

新聞資訊

強大的合作伙伴銷售業績推動Neuren Pharmaceuticals躍居澳大利亞行業基準榜首

若獲歐盟市場授權並上市，NEUREN PHARMACEUTICALS LTD 首筆商業銷售後將獲3500萬美元

Neuren Pharmaceuticals 正重新評估資本管理方案，包括延續股票回購與啓動税後股息

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/NEU.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":20.72,"timestamp":1789452720000,"preClose":20.52,"halted":0,"volume":352042,"delay":0,"changeRate":0.00974658869395708,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":108394581,"shares":126639526,"eps":0.155917,"marketStatus":"未開盤","change":0.2,"latestTime":"09-15 16:12:00 AEST","open":20.5,"high":21.01,"low":20.44,"amount":7291606,"amplitude":0.027778,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.155917,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":20.52,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.9469975957681787,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NEU.AU","preClose":20.72,"auctionPrice":20.85,"auctionVolume":207,"auctionTime":1789510691289,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789510691289}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":108394581,"roa":"2.58%","roe":"6.17%","lyrEps":0.2327,"volumeRatio":0.9469975957681787,"shares":126639526,"dividePrice":0,"high":21.01,"amplitude":0.027778,"preClose":20.52,"low":20.44,"week52Low":10.92,"pbRate":"7.87","psRate":"37.74","week52High":23.588,"institutionHeld":0,"latestPrice":20.72,"eps":0.155917,"divideRate":0,"volume":352042,"delay":0,"ttmEps":0.155917,"open":20.5,"prevYearClose":18.475,"prevWeekClose":20.103,"prevMonthClose":19.597,"prevQuarterClose":17.621,"fiveDayClose":20.49,"twentyDayClose":22.873,"sixtyDayClose":12.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"NEU.AU","amount":0.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-16","defaultRemindTime":1789430400000,"name":"NEUREN PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-07","payableDate":"2026-09-16","currency":"AUD","dateTimestamp":1789394400000,"payDate":"2026-10-07"},{"date":"2026-08-26","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2026-09-15","recordDate":"2026-09-16","paymentDate":"2026-10-07","value":0.15,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEU.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657946745","title":"強大的合作伙伴銷售業績推動Neuren Pharmaceuticals躍居澳大利亞行業基準榜首","url":"https://stock-news.laohu8.com/highlight/detail?id=2657946745","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657946745?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 11:34","pubTimestamp":1785900870,"startTime":"0","endTime":"0","summary":"BUZZ-强大的合作伙伴销售业绩推动Neuren Pharmaceuticals跃居澳大利亚行业基准榜首8月5日-**Neuren PharmaceuticalsNEU.AX股价一度上涨18.2%，至22.00澳元，创下自2025年10月31日以来的最高水平**** 该公司表示， (link) Acadia PharmaceuticalsACAD.O——NEU曾向其授予DAYBUE（特罗菲奈肽）口","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4T4420AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065171402.SGD","LU2065170008.USD","BK7508","LU2065171311.SGD","NEU.AU","BK7096","ACAD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183210271","title":"若獲歐盟市場授權並上市，NEUREN PHARMACEUTICALS LTD 首筆商業銷售後將獲3500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183210271","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183210271?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 05:45","pubTimestamp":1782683146,"startTime":"0","endTime":"0","summary":"若其产品在欧盟获得市场授权并成功上市，NEUREN PHARMACEUTICALS LTD 将在完成首笔商业销售后，有权获得3500万美元的款项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEU.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118300837","title":"Neuren Pharmaceuticals 正重新評估資本管理方案，包括延續股票回購與啓動税後股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1118300837","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118300837?lang=zh_tw&edition=fundamental","pubTime":"2026-05-27 11:24","pubTimestamp":1779852294,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals 目前正在对其资本管理策略进行全面重估。公司考虑的方案包括继续执行现有的股票回购计划，以及启动派发税后股息。这一评估旨在优化资本结构，提升股东回报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEU.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NEU.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.011805}]}}